Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

about

Apoptosis of multiple myeloma.eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.

P2860

Q33930178-6F8F72E2-2BC1-4DD7-9CF9-AD5DA4D17BF2 Q35552009-DAF40BBF-EA11-4E80-B9FA-4859EB14065F Q38972291-51431760-E1EF-4ABD-9AC5-6AEA825E3DF6

P2860

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

Item

http://www.wikidata.org/entity/Q40529674

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

@en

type

Item

label

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

@en

prefLabel

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

@en

P1476

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

@en

P2093

Alla Osadchy

http://www.w3.org/2001/XMLSchema#string

Hava Shapira

http://www.w3.org/2001/XMLSchema#string

Judith Radnay

http://www.w3.org/2001/XMLSchema#string

Liat Drucker

http://www.w3.org/2001/XMLSchema#string

Michael Lishner

http://www.w3.org/2001/XMLSchema#string

P2860

Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal

New insights into the interaction of Ras with the plasma membrane.

Fibronectin, integrins, and growth control.

Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity.

Molecular mechanisms of novel therapeutic approaches for multiple myeloma.

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway.

PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.

P304

183-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0609.2004.00284.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15287916

http://www.w3.org/2001/XMLSchema#string

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

about

P2860

P2860

Microenvironment factors do not afford myeloma cell lines protection from simvastatin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698